- Management of patients with ALK-positive advanced non-small cell lung cancer who received brain radiotherapy on study in the phase 3 CROWN trialBauer, Todd Michael; Felip, Enriqueta; Mok, Tony S. K.; Wu, Yi-Long; Liu, Geoffrey; Goto, Yasushi; Kim, Dong-Wan; Paolini, Jolanda; Polli, Anna; Solomon, Benjamin J.Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
- A prospective data analysis of targeted therapy combined with concurrent radiation therapy for brain metastasis from NSCLC with driver gene mutation.Duan, Xiaotong; Zhu, Xiaoxia; Wang, LijuanVirtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2021-06-04 To 2021-06-08.
- Survival Benefits of Radiotherapy and Surgery in Lung Cancer Brain Metastases with Poor Prognosis FactorsLiang, Lun; Wang, Zhenning; Duan, Hao; He, Zhenqiang; Lu, Jie; Jiang, Xiaobing; Hu, Hongrong; Li, Chang; Yu, Chengwei; Zhong, Sheng; Cui, Run; Guo, Xiaoyu; Deng, Meiling; Chen, Yuanyuan; Du, Xiaojing; Wu, Shaoxiong; Chen, Likun*; Mou, Yonggao*Current Oncology, 2023, 30(2): 2227-2236.
会议论文
SURVIVAL BENEFIT OF RADIOTHERAPY AND SURGERY IN PATIENTS WITH LUNG CANCER BRAIN METASTASES WITH POOR PROGNOSIS FACTORS
6阅读
